EPO Patents = 4

Forward Citations = 8

Loading Chart...

9 inventors (with patents filed for the assignee):

Marie-Edith Meyre (5 out of 16 patents)

Matthieu Germain (5 out of 12 patents)

Laurent Levy (3 out of 27 patents)

4. Agnes Pottier (3 out of 13 patents)

5. Agnès Pottier (2 out of 12 patents)

6. Audrey Darmon (2 out of 3 patents)

7. Laurence Poul (1 out of 5 patents)

8. Marion Paolini (1 out of 1 patent)

9. Celine Berjaud (1 out of 2 patents)

10. Céline Berjaud (0 patent)

5 patents: Sort by Forward Citations

1. 11471410 - Pharmaceutical composition combining at least two distinct nanoparticles and a pharmaceutical compound, preparation and uses thereof (2022-10-18),

2. 11357724 - Pharmaceutical composition, preparation and uses thereof (2022-06-14),

3. 11304902 - Pharmaceutical compositions, preparation and uses thereof (2022-04-19),

4. 11191846 - Methods of treatment utilizing biocompatible nanoparticles and therapeutic agents (2021-12-07),

5. 10765632 - Methods of improving delivery of compounds for therapy, prophylaxis or diagnosis (2020-09-08),

Company Overview

Curadigm is a biotechnology company that develops innovative solutions to enhance the delivery of drugs and vaccines by targeting the lymphatic system. Through its proprietary technology platform, Curadigm aims to improve the efficacy and safety of therapies for a wide range of diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#568 in Paris

#2,868 in France

Paris, France

Curadigm Sas

Forward Citations = 8

9 inventors:

Marie-Edith Meyre (5 out of 16 patents)

Matthieu Germain (5 out of 12 patents)

Laurent Levy (3 out of 27 patents)

4. Agnes Pottier (3 out of 13 patents)

5. Agnès Pottier (2 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Curadigm Sas. Retrieved from https://idiyas.com/company/curadigm-sas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]